Berberine activates thermogenesis in white and brown adipose tissue

Nature Communications

Volumn 5, Issue , 2014, Pages

  Zhang, Zhiguo ^a   Zhang, Huizhi ^a   Li, Bo ^a   Meng, Xiangjian ^a,b   Wang, Jiqiu ^a   Zhang, Yifei ^a   Yao, Shuangshuang ^a   Ma, Qinyun ^a   Jin, Lina ^a   Yang, Jian ^a   Wang, Weiqing ^a   Ning, Guang ^a  

^a State Key Laboratory of Medical Genomics   (China)

^b WANNAN MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE KINASE; BERBERINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; UNCOUPLING PROTEIN 1; HERBACEOUS AGENT;

ALKALOID; DICOTYLEDON; ENERGY BALANCE; ENERGY USE; GENE EXPRESSION; MEDICINAL PLANT; OBESITY; WEIGHT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BROWN ADIPOCYTE; BROWN ADIPOSE TISSUE; COLD TOLERANCE; CONTROLLED STUDY; ENERGY BALANCE; ENERGY EXPENDITURE; ENZYME ACTIVITY; ENZYME INHIBITION; EPIDIDYMIS FAT; HYPOTHALAMUS; INGUINAL REGION; MALE; MOUSE; NONHUMAN; OBESITY; PROTEIN EXPRESSION; THALAMUS VENTRAL NUCLEUS; THERMOGENESIS; WEIGHT GAIN; WEIGHT REDUCTION; WHITE ADIPOSE TISSUE; ANIMAL; C3H MOUSE; C57BL MOUSE; DRUG EFFECTS; ENERGY METABOLISM; HUMAN; METABOLISM; PATHOPHYSIOLOGY;

COPTIS CHINENSIS; MUS;

ADIPOSE TISSUE, BROWN; ADIPOSE TISSUE, WHITE; ANIMALS; BERBERINE; DRUGS, CHINESE HERBAL; ENERGY METABOLISM; HUMANS; MALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; OBESITY; THERMOGENESIS;

EID: 84923329319     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms6493     Document Type: Article

References (70)

1. Haslam, D. W. & James, W. P. Obesity. Lancet 366, 1197-1209 (2005).
2. Tseng, Y. H., Cypess, A. M. & Kahn, C. R. Cellular bioenergetics as a target for obesity therapy. Nat. Rev. Drug Discov. 9, 465-482 (2010).
3. Vernochet, C. et al. Adipose-specific deletion of TFAM increases mitochondrial oxidation and protects mice against obesity and insulin resistance. Cell Metab. 16, 765-776 (2012).
4. Guilherme, A., Virbasius, J. V., Puri, V. & Czech, M. P. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat. Rev. Mol. Cell Biol. 9, 367-377 (2008).
5. Rosen, E. D. & Spiegelman, B. M. What we talk about when we talk about fat. Cell 156, 20-44 (2014).
6. Lazar, M. A. Developmental biology. How now, brown fat? Science 321, 1048-1049 (2008).
7. Rosenwald, M., Perdikari, A., Rulicke, T. & Wolfrum, C. Bi-directional interconversion of brite and white adipocytes. Nat. Cell Biol. 15, 659-667 (2013).
8. Bartelt, A. & Heeren, J. Adipose tissue browning and metabolic health. Nature reviews. Endocrinology 10, 24-36 (2014).
9. Cypess, A. M. et al. Identification and importance of brown adipose tissue in adult humans. N. Engl. J. Med. 360, 1509-1517 (2009).
10. van Marken Lichtenbelt, W. D. et al. Cold-activated brown adipose tissue in healthy men. New Engl. J. Med. 360, 1500-1508 (2009).
11. Virtanen, K. A. et al. Functional brown adipose tissue in healthy adults. New Engl. J. Med. 360, 1518-1525 (2009).
12. Langin, D. Recruitment of brown fat and conversion of white into brown adipocytes: strategies to fight the metabolic complications of obesity? Biochim. Biophys. Acta 1801, 372-376 (2010).
13. Lee, Y. S. et al. Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes 55, 2256-2264 (2006).
14. Kong, W. et al. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat. Med. 10, 1344-1351 (2004).
15. Turner, N. et al. Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action. Diabetes 57, 1414-1418 (2008).
16. Zhang, Y. et al. Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. J. Clin. Endocrinol. Metab. 93, 2559-2565 (2008).
17. Ma, X. et al. Berberine-induced activation of 5'-adenosine monophosphateactivated protein kinase and glucose transport in rat skeletal muscles. Metabolism 59, 1619-1627 (2010).
18. Cheng, Z. et al. Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK. Biochim. Biophys. Acta 1760, 1682-1689 (2006).
19. Chang, W. et al. Berberine improves insulin resistance in cardiomyocytes via activation of 5'-adenosine monophosphate-activated protein kinase. Metabolism 62, 1159-1167 (2013).
20. Collins, S. beta-Adrenoceptor Signaling Networks in Adipocytes for Recruiting Stored Fat and Energy Expenditure. Front. Endocrinol. 2, 102 (2011).
21. Bal, N. C. et al. Sarcolipin is a newly identified regulator of muscle-based thermogenesis in mammals. Nat. Med. 18, 1575-1579 (2012).
22. Puigserver, P. et al. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92, 829-839 (1998).
23. Pan, D., Fujimoto, M., Lopes, A. & Wang, Y. X. Twist-1 is a PPARdeltainducible, negative-feedback regulator of PGC-1alpha in brown fat metabolism. Cell 137, 73-86 (2009).
24. Handschin, C., Rhee, J., Lin, J., Tarr, P. T. & Spiegelman, B. M. An autoregulatory loop controls peroxisome proliferator-activated receptor gamma coactivator 1alpha expression in muscle. Proc. Natl Acad. Sci. USA 100, 7111-7116 (2003).
25. Minokoshi, Y. et al. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 428, 569-574 (2004).
26. Lopez, M. et al. Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance. Nat. Med. 16, 1001-1008 (2010).
27. Kahn, B. B., Alquier, T., Carling, D. & Hardie, D. G. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 1, 15-25 (2005).
28. Cypess, A. M. & Kahn, C. R. Brown fat as a therapy for obesity and diabetes. Curr. Opin. Endocrinol. Diabetes Obes. 17, 143-149 (2010).
29. Kiefer, F. W. et al. Retinaldehyde dehydrogenase 1 regulates a thermogenic program in white adipose tissue. Nat. Med. 18, 918-925 (2012).
30. Liu, Y., Ghesani, N. V. & Zuckier, L. S. Physiology and pathophysiology of incidental findings detected on FDG-PET scintigraphy. Semin. Nucl. Med. 40, 294-315 (2010).
31. Feldmann, H. M., Golozoubova, V., Cannon, B. & Nedergaard, J. UCP1 ablation induces obesity and abolishes diet-induced thermogenesis in mice exempt from thermal stress by living at thermoneutrality. Cell Metab. 9, 203-209 (2009).
32. Seale, P. et al. PRDM16 controls a brown fat/skeletal muscle switch. Nature 454, 961-967 (2008).
33. Lepper, C. & Fan, C. M. Inducible lineage tracing of Pax7-descendant cells reveals embryonic origin of adult satellite cells. Genesis 48, 424-436 (2010).
34. Cinti, S. Reversible physiological transdifferentiation in the adipose organ. Proc. Nutr. Soc. 68, 340-349 (2009).
35. Ghorbani, M. & Himms-Hagen, J. Appearance of brown adipocytes in white adipose tissue during CL 316,243-induced reversal of obesity and diabetes in Zucker fa/fa rats. Int. J. Obes. Relat. Metab. Disord. 21, 465-475 (1997).
36. Barbatelli, G. et al. The emergence of cold-induced brown adipocytes in mouse white fat depots is determined predominantly by white to brown adipocyte transdifferentiation. Am. J. Physiol. Endocrinol. Metab. 298, E1244-E1253 (2010).
37. Petrovic, N. et al. Chronic peroxisome proliferator-activated receptor gamma (PPARgamma) activation of epididymally derived white adipocyte cultures reveals a population of thermogenically competent, UCP1-containing adipocytes molecularly distinct from classic brown adipocytes. J. Biol. Chem. 285, 7153-7164 (2010).
38. Harms, M. & Seale, P. Brown and beige fat: development, function and therapeutic potential. Nat. Med. 19, 1252-1263 (2013).
39. Huang, C. et al. Berberine inhibits 3T3-L1 adipocyte differentiation through the PPARgamma pathway. Biochem. Biophys. Res. Commun. 348, 571-578 (2006).
40. Eberhard, D. & Tosh, D. Transdifferentiation and metaplasia as a paradigm for understanding development and disease. Cell. Mol. Life Sci. 65, 33-40 (2008).
41. Cinti, S. Adipocyte differentiation and transdifferentiation: plasticity of the adipose organ. J. Endocrinol. Invest. 25, 823-835 (2002).
42. Virtanen, K. A. & Nuutila, P. Brown adipose tissue in humans. Curr. Opin. Lipidol. 22, 49-54 (2011).
43. Perwitz, N. et al. Cannabinoid type 1 receptor blockade induces transdifferentiation towards a brown fat phenotype in white adipocytes. Diabetes Obes. Metab. 12, 158-166 (2010).
44. Granneman, J. G., Li, P., Zhu, Z. & Lu, Y. Metabolic and cellular plasticity in white adipose tissue I: effects of beta3-adrenergic receptor activation. Am. J. Physiol. Endocrinol. Metab. 289, E608-E616 (2005).
45. Wu, J. et al. Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell 150, 366-376 (2012).
46. Lee, Y. H., Petkova, A. P., Mottillo, E. P. & Granneman, J. G. In vivo identification of bipotential adipocyte progenitors recruited by beta3- adrenoceptor activation and high-fat feeding. Cell Metab. 15, 480-491 (2012).
47. Seale, P. et al. Prdm16 determines the thermogenic program of subcutaneous white adipose tissue in mice. J. Clin. Invest. 121, 96-105 (2011).
48. Murano, I., Barbatelli, G., Giordano, A. & Cinti, S. Noradrenergic parenchymal nerve fiber branching after cold acclimatisation correlates with brown adipocyte density in mouse adipose organ. J. Anat. 214, 171-178 (2009).
49. Seale, P. et al. Transcriptional control of brown fat determination by PRDM16. Cell Metab. 6, 38-54 (2007).
50. Guerra, C., Koza, R. A., Yamashita, H., Walsh, K. & Kozak, L. P. Emergence of brown adipocytes in white fat in mice is under genetic control. Effects on body weight and adiposity. J. Clin. Invest. 102, 412 (1998).
51. Lin, J., Handschin, C. & Spiegelman, B. M. Metabolic control through the PGC- 1 family of transcription coactivators. Cell Metab. 1, 361-370 (2005).
52. Tiraby, C. et al. Acquirement of brown fat cell features by human white adipocytes. J. Biol. Chem. 278, 33370-33376 (2003).
53. Zong, H. et al. AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation. Proc. Natl Acad. Sci. USA 99, 15983-15987 (2002).
54. Canto, C. et al. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 458, 1056-1060 (2009).
55. Canto, C. & Auwerx, J. PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure. Curr. Opin. Lipidol. 20, 98-105 (2009).
56. Suwa, M., Nakano, H. & Kumagai, S. Effects of chronic AICAR treatment on fiber composition, enzyme activity, UCP3, and PGC-1 in rat muscles. J. Appl. Physiol. 95, 960-968 (2003).
57. Jager, S., Handschin, C., St-Pierre, J. & Spiegelman, B. M. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proc. Natl Acad. Sci. USA 104, 12017-12022 (2007).
58. Yin, J., Gao, Z., Liu, D., Liu, Z. & Ye, J. Berberine improves glucose metabolism through induction of glycolysis. Am. J. Physiol. Endocrinol. Metab. 294, E148-E156 (2008).
59. Xu, M. et al. Berberine promotes glucose consumption independently of AMPactivated protein kinase activation. PloS ONE 9, e103702 (2014).
60. Gaidhu, M. P. et al. Chronic AMP-kinase activation with AICAR reduces adiposity by remodeling adipocyte metabolism and increasing leptin sensitivity. J. Lipid Res. 52, 1702-1711 (2011).
61. Vila-Bedmar, R., Lorenzo, M. & Fernandez-Veledo, S. Adenosine 5'-monophosphate-activated protein kinase-mammalian target of rapamycin cross talk regulates brown adipocyte differentiation. Endocrinology 151, 980-992 (2010).
62. Martinez de Morentin, P. B. et al. Estradiol regulates brown adipose tissue thermogenesis via hypothalamic AMPK. Cell Metab. 20, 41-53 (2014).
63. Whittle, A. J. et al. BMP8B increases brown adipose tissue thermogenesis through both central and peripheral actions. Cell 149, 871-885 (2012).
64. Tseng, Y. H., Kriauciunas, K. M., Kokkotou, E. & Kahn, C. R. Differential roles of insulin receptor substrates in brown adipocyte differentiation. Mol. Cell Biol. 24, 1918-1929 (2004).
65. Soukas, A., Socci, N. D., Saatkamp, B. D., Novelli, S. & Friedman, J. M. Distinct transcriptional profiles of adipogenesis in vivo and in vitro. J. Biol. Chem. 276, 34167-34174 (2001).
66. Klein, J. et al. beta(3)-adrenergic stimulation differentially inhibits insulin signaling and decreases insulin-induced glucose uptake in brown adipocytes. J. Biol. Chem. 274, 34795-34802 (1999).
67. Kim, M. S. et al. Anti-obesity effects of alpha-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase. Nat. Med. 10, 727-733 (2004).
68. Tseng, Y. H. et al. New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure. Nature 454, 1000-1004 (2008).
69. Franklin, K. B. J. & Paxinos, G. The Mouse Brain in Stereotaxic Coodinates (Academic Press, 1997).
70. Lagouge, M. et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127, 1109-1122 (2006).